Literature DB >> 18391585

Adeno-associated virus vectors: versatile tools for in vivo gene transfer.

Lorena Zentilin1, Mauro Giacca.   

Abstract

Over the last few years, viral vectors based on the adeno-associated virus have gained increasing popularity due to several favorable characteristics, including the high efficiency of transduction of postmitotic tissues in vivo and the long-term persistence of transgene expression in the absence of inflammation or immune response. Recently, completed trials have substantially confirmed the clinical applicability of these vectors, while indicating that further developments in vector design and production scale are necessary to broaden human application. This review summarizes our current knowledge on the molecular biology of these vectors and their clinical utilization, in particular concerning their application in renal gene transfer.

Entities:  

Mesh:

Year:  2008        PMID: 18391585     DOI: 10.1159/000125584

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  3 in total

1.  Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle.

Authors:  Andrey Anisimov; Annamari Alitalo; Petra Korpisalo; Jarkko Soronen; Seppo Kaijalainen; Veli-Matti Leppänen; Michael Jeltsch; Seppo Ylä-Herttuala; Kari Alitalo
Journal:  Circ Res       Date:  2009-05-14       Impact factor: 17.367

2.  AAV-iRFP labelling of human mesenchymal stem cells for near-infrared fluorescence imaging.

Authors:  Can Huang; Wenjun Lan; Feifei Wang; Chun Zhang; Xiaomei Liu; Qin Chen
Journal:  Biosci Rep       Date:  2017-04-28       Impact factor: 3.840

3.  Effect of vascular endothelial growth factor gene therapy on post-traumatic peripheral nerve regeneration and denervation-related muscle atrophy.

Authors:  S Moimas; F Novati; G Ronchi; S Zacchigna; F Fregnan; L Zentilin; G Papa; M Giacca; S Geuna; I Perroteau; Z M Arnež; S Raimondo
Journal:  Gene Ther       Date:  2013-05-30       Impact factor: 5.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.